Human Technopole and University of Milan sign agreement
12 June 2019 – The Rector of Università Statale in Milan Elio Franzini and the President of Human Technopole Marco Simoni met today to sign a partnership agreement that foresees a series of important collaborations in the fields of science and education between the two institutions.
The agreement lays the foundation for synergies in the use of laboratories and research facilities, the exchange of research staff at all levels, the development of research projects and programs in areas of common interest and joint public engagement activities. Further details will be set in subsequent and specific program agreements.
Elio Franzini, Rector of the University, commented: “Today we begin an important collaboration between our University and Human Technopole in a great variety of areas of common interest, particularly in the field of life sciences. This will allow synergies and strategic opportunities for both institutions, enhancing our potential in scientific research and education, in the development of international networks and projects, in technological innovation and in the dissemination of scientific culture”.
“We are proud to start from Milan and Università Statale with the first of a series of agreements that we intend to sign with various Italian universities to facilitate the exchange of information and resources and create opportunities for mutual development”, underlined President Marco Simoni. “Human Technopole has the ambition to be an institution open to collaborations with universities, hospitals, institutions and centers. To enrich and add value to the existing ecosystem of Italian research.
Share:
You could also like:
-
Colorectal Cancer: ML Enhances Cetuximab Response Predictions
An international collaborative study led by Human Technopole, Candiolo Cancer Institute IRCCS in Turin, the University of Turin, and the Wellcome Sanger Institute in Cambridge (UK) has identified new factors associated with therapeutic response in colorectal cancer. The research has led to the development of a machine-learning model capable of accurately predicting the effects of cetuximab, a drug in clinical use, on different colorectal tumour subtypes. Funded by the AIRC Foundation, the study paves the way to identifying molecular features that could serve as biomarkers for predicting treatment response in patients with this type of cancer.
-
Human Technopole Foundation’s Supplier List online
The Human Technopole Foundation’s Supplier Register is now online.
-
HT Director Zerial Awarded Mercurio Prize for Excellence in Research
The Human Technopole Director, Marino Zerial, has been awarded the 2024 Mercurio Prize in the “Research and Development” category, in recognition of the excellence of his research in the field of cell biology. Zerial, renowned for his studies on the mechanisms of endocytosis and cellular transport, has made significant contributions to the understanding of cellular dynamics, with potential therapeutic applications for diseases such as liver conditions.
-
A new model system for cortical development in vitro
Researchers from Human Technopole, the Institute of Molecular Biotechnology and Bicocca University established a method for developing brain assembloids that allows reproducing salient aspects of the antero-posterior polarity of the human cerebral cortex in vitro and opens new possibilities for disease modelling. The study is published in Nature Methods.
-
The National Facility for Genomics with Clelia Peano
Meet Clelia Peano, Head of the National Facility for Genomics. The Facility offers cutting-edge services to develop robust experimental and analytical workflows to explore different genomic research areas, including DNA and RNA analysis, chromatin structure, and epigenetic mechanisms regulating transcription. The goal is to enhance genomic research in all its aspects, benefiting the entire Italian scientific community.